DR30206
- Generic Name
- DR30206
Evaluate the Safety, Tolerability, Pharmacokinetics of DR30206 in Patients With Advanced or Metastatic Solid Tumors
- First Posted Date
- 2023-11-15
- Last Posted Date
- 2024-07-30
- Lead Sponsor
- Zhejiang Doer Biologics Co., Ltd.
- Target Recruit Count
- 182
- Registration Number
- NCT06132828
- Locations
- 🇨🇳
Shanghai Pulmonary Hospital, Shanghai, Shanghai, China
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath